D2 Resection and HIPEC (Hyperthermic Intraperitoneal Chemoperfusion) in Locally Advanced Gastric Carcinoma (GASTRICHIP)
GASTRICHIP : D2 Resection and HIPEC (Hyperthermic Intraperitoneal Chemoperfusion) in Locally Advanced Gastric Carcinoma. A Randomized and Multicentric Phase III Study.
Sponsor: Hospices Civils de Lyon
A PHASE3 clinical study on Gastric Adenocarcinoma, this trial is ongoing. The trial is conducted by Hospices Civils de Lyon and has accumulated 13 data snapshots since 2013. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.
Status Flow
Change History
13 versions recorded-
Sep 2025 — Present [monthly]
Active Not Recruiting PHASE3
-
Sep 2024 — Sep 2025 [monthly]
Active Not Recruiting PHASE3
-
Jul 2024 — Sep 2024 [monthly]
Active Not Recruiting PHASE3
-
Jun 2024 — Jul 2024 [monthly]
Active Not Recruiting PHASE3
-
May 2023 — Jun 2024 [monthly]
Active Not Recruiting PHASE3
▶ Show 8 earlier versions
-
Feb 2022 — May 2023 [monthly]
Active Not Recruiting PHASE3
-
Sep 2021 — Feb 2022 [monthly]
Active Not Recruiting PHASE3
Status: Recruiting → Active Not Recruiting
-
Jan 2021 — Sep 2021 [monthly]
Recruiting PHASE3
-
Feb 2020 — Jan 2021 [monthly]
Recruiting PHASE3
-
Feb 2019 — Feb 2020 [monthly]
Recruiting PHASE3
-
Jun 2018 — Feb 2019 [monthly]
Recruiting PHASE3
-
Jun 2017 — Jun 2018 [monthly]
Recruiting PHASE3
-
Jan 2017 — Jun 2017 [monthly]
Recruiting PHASE3
First recorded
Jun 2013
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Hospices Civils de Lyon
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
Alcalá de Henares, Spain , Amiens, France , Angers, France , Barcelona, Spain , Besançon, France , Caen, France , Clermont-Ferrand, France , Dijon, France , Grenoble, France , Lille, France and 16 more locations